Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Pegylated Liposomal Doxorubicin and Carboplatin as First Line Treatment for Patients With Advanced Non-small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01051362
Recruitment Status : Unknown
Verified January 2006 by The First Affiliated Hospital of Guangzhou Medical University.
Recruitment status was:  Recruiting
First Posted : January 18, 2010
Last Update Posted : January 18, 2010
Sponsor:
Information provided by:
The First Affiliated Hospital of Guangzhou Medical University